1.43
price down icon7.14%   -0.11
after-market アフターアワーズ: 1.50 0.07 +4.90%
loading
前日終値:
$1.54
開ける:
$1.56
24時間の取引高:
263.63K
Relative Volume:
0.36
時価総額:
$110.41M
収益:
$139.77M
当期純損益:
$-97.62M
株価収益率:
-0.9051
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
-18.29%
1か月 パフォーマンス:
+12.60%
6か月 パフォーマンス:
-67.13%
1年 パフォーマンス:
-90.25%
1日の値動き範囲:
Value
$1.42
$1.60
1週間の範囲:
Value
$1.42
$1.74
52週間の値動き範囲:
Value
$0.9897
$5.77

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1153)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
341
Name
Twitter
@macrogenics
Name
次回の収益日
2025-03-07
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

MGNX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
MGNX
Macrogenics Inc
1.43 110.41M 139.77M -97.62M -61.71M -1.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.99 128.84B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.78 65.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
549.65 39.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.15 33.82B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
231.99 27.60B 3.81B -644.79M -669.77M -6.24

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
05:51 AM

Class Action Filed Against MacroGenics, Inc. (MGNX)September 24, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

05:51 AM
pulisher
04:47 AM

Price T Rowe Associates Inc. MD Decreases Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - The AM Reporter

04:47 AM
pulisher
02:29 AM

MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

02:29 AM
pulisher
May 08, 2025

MacroGenics at Citizens JMP Life Sciences Conference: Strategic Pipeline Insights - Investing.com Australia

May 08, 2025
pulisher
May 07, 2025

MacroGenics Announces Date of First Quarter 2025 Financial Results - GlobeNewswire

May 07, 2025
pulisher
May 06, 2025

MacroGenics Announces Date of First Quarter 2025 Financial Resul - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Levi & Korsinsky Reminds MacroGenics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - ACCESS Newswire

May 06, 2025
pulisher
May 05, 2025

MacroGenics, Inc. Class Action: Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - ACCESS Newswire

May 05, 2025
pulisher
May 05, 2025

MacroGenics Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

Macrogenics Inc: Is MGNX Stock Worth Buying? - Stocksregister

May 05, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 02, 2025

LPL Financial LLC Sells 8,500 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

May 02, 2025
pulisher
May 01, 2025

MacroGenics to Participate in Upcoming Investor Conference | MGN - GuruFocus

May 01, 2025
pulisher
May 01, 2025

MacroGenics to Participate in Upcoming Investor Conference | MGNX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

MacroGenics to Participate in Upcoming Investor Conference - The Manila Times

May 01, 2025
pulisher
May 01, 2025

MacroGenics Announces Exclusive Fireside Chat at Major Life Sciences ConferenceKey Details Inside - Stock Titan

May 01, 2025
pulisher
May 01, 2025

A year in review: Macrogenics Inc (MGNX)’s performance in the last year - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Quarterly Snapshot: Quick and Current Ratios for Macrogenics Inc (MGNX) - DWinneX

May 01, 2025
pulisher
May 01, 2025

MacroGenics (MGNX) to Release Earnings on Thursday - Defense World

May 01, 2025
pulisher
Apr 27, 2025

MacroGenics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 27, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Holdings Increased by Geode Capital Management LLC - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

JPMorgan Chase & Co. Acquires 221,905 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

Apr 25, 2025
pulisher
Apr 23, 2025

MGNXMacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN

Apr 23, 2025
pulisher
Apr 22, 2025

The MGNX Stock Puzzle: Unraveling Macrogenics Inc’s Fluctuating Performance - investchronicle.com

Apr 22, 2025
pulisher
Apr 21, 2025

MacroGenics Provides Update on Corporate Progress and 1st Quarter 2017 Financial Results - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

MacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN

Apr 21, 2025

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):